title: Genetic variants of a BH3-only pro-apoptotic gene, PUMA, and risk of HPV16-associated squamous cell carcinoma of the head and neck.
abstract: P53 up-regulated modulator of apoptosis (PUMA) is a critical factor in the intrinsic apoptotic pathway. Through PUMA-dependent mechanisms, human papillomavirus 16 (HPV16) oncoprotein may affect apoptosis by E6-mediated p53 degradation. To examine whether the PUMA variants modify the association between HPV16 serology and risk of squamous cell carcinoma of the head and neck (SCCHN), we genotyped two polymorphisms in the PUMA promoter (rs3810294 and rs2032809) in 380 cases and 335 cancer-free controls of non-Hispanic Whites, who were frequency-matched by age (±5 yr), sex, smoking, and drinking status. We found that each individual polymorphism had only a modest impact on risk of SCCHN, particularly in oropharyngeal cancer for rs3810294 and non-oropharyngeal cancer for rs2032809. After we stratified the individuals by HPV16 serology, and used those with the corresponding common homozygous genotype and HPV16 seronegativity as the reference group, for each polymorphism we found that the risk of SCCHN associated with HPV16 seropositivity was higher among those with variant genotypes than those with the corresponding common homozygous genotype. Notably, this effect modification was particularly pronounced in several subgroups including never smokers, never drinkers, younger patients, and patients with oropharyngeal cancer. Furthermore, we also characterized the functional relevance of the two polymorphisms to explore the genotype-phenotype correlation. Our results suggested that the PUMA promoter polymorphisms may be a biomarker for risk of HPV16-associated SCCHN, particularly in never smokers, never drinkers, younger patients, and patients with oropharyngeal cancer. Larger studies are needed to validate our findings.
authors.affiliation: Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
authors.forename: Ziyuan
authors.initials: Z
authors.lastname: Zhou
authors.forename: Erich M
authors.initials: EM
authors.lastname: Sturgis
authors.forename: Zhensheng
authors.initials: Z
authors.lastname: Liu
authors.forename: Li-E
authors.initials: LE
authors.lastname: Wang
authors.forename: Qingyi
authors.initials: Q
authors.lastname: Wei
authors.forename: Guojun
authors.initials: G
authors.lastname: Li
mesh_terms: D000328:Adult; D000368:Aged; D051017:Apoptosis Regulatory Proteins / Q000235:genetics*; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000821:virology*; D016022:Case-Control Studies; D005260:Female; D056726:Genetic Association Studies; D006258:Head and Neck Neoplasms / Q000235:genetics* / Q000821:virology*; D052162:Human papillomavirus 16; D006801:Humans; D008297:Male; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000150:complications / Q000821:virology; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D012307:Risk Factors; D000077195:Squamous Cell Carcinoma of Head and Neck
chemical_list: D051017:Apoptosis Regulatory Proteins; C438378:BBC3 protein, human; D011518:Proto-Oncogene Proteins
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
references.pmid: 15734974
references.citation: Mol Cell. 2001 Mar;7(3):673-82
references.pmid: 11463391
references.citation: J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83
references.pmid: 14652239
references.citation: J Clin Oncol. 2007 Oct 10;25(29):4550-6
references.pmid: 17925550
references.citation: Cancer Res. 2005 Mar 1;65(5):1647-54
references.pmid: 15753358
references.citation: J Mol Biol. 2008 Dec 12;384(2):313-23
references.pmid: 18835564
references.citation: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references.pmid: 20610543
references.citation: J Biol Chem. 2010 Apr 23;285(17):13201-10
references.pmid: 20167600
references.citation: Oncogene. 2006 Jul 6;25(29):4009-15
references.pmid: 16462759
references.citation: J Natl Cancer Inst. 2007 Dec 5;99(23):1801-10
references.pmid: 18042931
references.citation: Cancer. 2008 Dec 15;113(12):3307-14
references.pmid: 18988287
references.citation: Cancer Res. 2010 Apr 15;70(8):3372-81
references.pmid: 20395210
references.citation: Oncogene. 2009 Jun 18;28(24):2348-57
references.pmid: 19421143
references.citation: Mol Cancer. 2010 Sep 02;9:229
references.pmid: 20813046
references.citation: Carcinogenesis. 2008 Apr;29(4):875-9
references.pmid: 18258602
references.citation: Cancer Res. 2010 Sep 15;70(18):7199-208
references.pmid: 20736372
references.citation: Cancer. 2008 Nov 15;113(10 Suppl):2981-94
references.pmid: 18980282
references.citation: J Natl Cancer Inst. 1994 Apr 6;86(7):494-9
references.pmid: 8133532
references.citation: Clin Otolaryngol. 2006 Aug;31(4):259-66
references.pmid: 16911640
references.citation: Hepatology. 2011 Oct;54(4):1249-58
references.pmid: 21725994
references.citation: J Clin Oncol. 2008 Feb 1;26(4):612-9
references.pmid: 18235120
references.citation: Cancer Res. 2009 Jun 15;69(12):4999-5006
references.pmid: 19491259
references.citation: Int J Cancer. 2007 Jun 1;120(11):2386-92
references.pmid: 17315185
references.citation: Nucleic Acids Res. 1991 May 11;19(9):2499
references.pmid: 2041787
references.citation: J Natl Cancer Inst. 2000 May 3;92(9):709-20
references.pmid: 10793107
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2379-88
references.pmid: 20826835
references.citation: Head Neck. 2011 Jun;33(6):847-55
references.pmid: 20737488
references.citation: Cell Death Differ. 2009 May;16(5):684-96
references.pmid: 19148184
references.citation: Head Neck Oncol. 2010 Jun 29;2:15
references.pmid: 20587061
references.citation: Head Neck. 2011 Jun;33(6):878-85
references.pmid: 20737492
references.citation: Lancet Oncol. 2010 Aug;11(8):781-9
references.pmid: 20451455
references.citation: Cancer Lett. 2003 Sep 10;199(1):75-81
references.pmid: 12963126
references.citation: Head Neck. 2011 May;33(5):650-60
references.pmid: 20949447
references.citation: Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3180-8
references.pmid: 18089712
references.citation: Oncogene. 2008 Dec;27 Suppl 1:S71-83
references.pmid: 19641508
references.citation: Cancer. 2007 Oct 1;110(7):1429-35
references.pmid: 17724670
references.citation: J Neurosci. 2006 Jul 5;26(27):7257-64
references.pmid: 16822983
references.citation: Cancer Sci. 2007 Oct;98(10):1505-11
references.pmid: 17645777
references.citation: Cell Res. 2009 Aug;19(8):1018-30
references.pmid: 19417777
references.citation: Mol Cell. 2010 May 14;38(3):356-68
references.pmid: 20471942
references.citation: Cancer Cell. 2003 Oct;4(4):248-9
references.pmid: 14585351
references.citation: J Biol Chem. 2008 Dec 26;283(52):36344-53
references.pmid: 18990690